-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Disc Medicine, Raises Price Target to $124

Benzinga·10/20/2026 13:56:06
Diffusion vocale
Wells Fargo analyst Derek Archila maintains Disc Medicine (NASDAQ:IRON) with a Overweight and raises the price target from $86 to $124.